Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Diagnosis and Management of Adrenocortical Carcinoma
Vania Balderrama-Brondani
, Mouhammed Amir Habra
Endocrine Neoplasia & HD
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Diagnosis and Management of Adrenocortical Carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adrenocortical Carcinoma
100%
Malignancy
33%
Surgical Resection
33%
Tyrosine Kinase Inhibitor
33%
Curative Treatment
33%
Doxorubicin
33%
Recurrent Disease
33%
Cisplatin
33%
Radiation Therapy
33%
Ki-67 Index
33%
Etoposide
33%
Image-guided
33%
Cell-based
33%
Accurate Diagnosis
33%
Histopathological Examination
33%
Risk Stratification
33%
Treatment Decisions
33%
Locoregional Therapy
33%
Investigational Therapies
33%
Radiological Assessment
33%
Mass Effect
33%
Approved Drugs
33%
Hormonal Assay
33%
Mitotane
33%
Hypercortisolism
33%
Immune Checkpoint Inhibitors
33%
Comprehensive Clinical Evaluation
33%
Resection Margin Status
33%
Medicine and Dentistry
Adrenal Cortex Carcinoma
100%
Cancer
33%
Recurrent Disease
33%
Cisplatin
33%
Radiation Therapy
33%
Doxorubicin
33%
Surgical Margin
33%
Etoposide
33%
Cell Therapy
33%
Tyrosine-Kinase Inhibitor
33%
Experimental Therapy
33%
Risk Stratification
33%
Hypercortisolism
33%
Mitotane
33%
Immune Checkpoint Inhibitor
33%